Camussi G et al. |
Immune-induced leucopenia. A role for the aggregation of polymorphonuclear neutrophils in systemic lupus erythematosus (SLE). |
1981 Jul-Sep |
Minerva Nefrol |
pmid:7329598
|
Camussi G et al. |
In vitro spasmogenic effect of platelet-activating factor on rabbit lung tissue. |
1981 Jul-Sep |
Panminerva Med |
pmid:7335369
|
Brown JE and Thuy LP |
The binding of bovine platelet aggregating factor to human platelets. |
1981 Apr 1-15 |
Thromb. Res. |
pmid:7292446
|
O'Flaherty JT et al. |
Neutrophil-degranulating action of 5,12-dihydroxy-6,8,10,14-eicosatetraenoic acid and 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine. Comparison with other degranulating agents. |
1981 |
Am. J. Pathol. |
pmid:6274199
|
Camussi G et al. |
Release of platelet-activating factor (PAF) and histamine. II. The cellular origin of human PAF: monocytes, polymorphonuclear neutrophils and basophils. |
1981 |
Immunology |
pmid:6161885
|
Renooij W and Snyder F |
Biosynthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor and a hypotensive lipid) by cholinephosphotransferase in various rat tissues. |
1981 |
Biochim. Biophys. Acta |
pmid:6260215
|
Mencia-Huerta JM and Benveniste J |
Platelet-activating factor (PAF-acether) and macrophages. II. Phagocytosis-associated release of PAF-acether from rat peritoneal macrophages. |
1981 |
Cell. Immunol. |
pmid:6260384
|
O'Flaherty JT et al. |
Evidence for 5, 12-dihydroxy-6,8,10,14-eicosatetraenoate as a mediator of human neutrophil aggregation. |
1981 |
Biochem. Biophys. Res. Commun. |
pmid:6277309
|
Cox CP et al. |
The presence of platelet-activating factor (PAF) in normal human mixed saliva. |
1981 |
J. Immunol. |
pmid:7240750
|
O'Donnell MC et al. |
Platelet activating factor: an inhibitor of neutrophil activation? |
1981 |
Clin. Exp. Immunol. |
pmid:7249391
|
Findlay SR et al. |
Contraction of guinea pig ileal smooth muscle by acetyl glyceryl ether phosphorylcholine. |
1981 |
Am. J. Physiol. |
pmid:7282914
|
Demopoulos CA et al. |
Intravascular pathobiology of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF). I. Intravenous infusion in guinea pigs. |
1981 |
Immunol. Lett. |
pmid:7287060
|
Halonen M et al. |
Differential effects of platelet depletion on the physiologic alterations of IgE anaphylaxis and acetyl glyceryl ether phosphorylcholine infusion in the rabbit. |
1981 |
Am. Rev. Respir. Dis. |
pmid:7294504
|
Wykle RL et al. |
Stereospecific activity of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine and comparison of analogs in the degranulation of platelets and neutrophils. |
1981 |
Biochem. Biophys. Res. Commun. |
pmid:7295320
|
O'Flaherty JT et al. |
Neutrophil responses to platelet-activating factor. |
1981 |
Inflammation |
pmid:7298160
|
Mencia-Huerta JM et al. |
Release of a slow-reacting substance from rabbit platelets. |
1981 |
J. Clin. Invest. |
pmid:6119324
|
Chap H et al. |
Biosynthetic labelling of platelet activating factor from radioactive acetate by stimulated platelets. |
1981 |
Nature |
pmid:7453828
|
Czarnetzki BM and Benveniste J |
Effect of synthetic PAF-acether on human neutrophil function. |
1981 |
Agents Actions |
pmid:7041568
|
Camussi G et al. |
Neutropenia induced by platelet-activating factor (PAF-acether) released from neutrophils: the inhibitory effect of prostacyclin (PGI2). |
1981 |
Agents Actions |
pmid:7041569
|
Vargaftig BB et al. |
Present concepts on the mechanisms of platelet aggregation. |
1981 |
Biochem. Pharmacol. |
pmid:7011325
|